CTIS.eu › Cities › France › Paris Cedex 18
Paris Cedex 18
France
258 total trials
103 recruiting
2024-513653-75-00
5
2022-05-30
Eosinophilic granulomatosis with polyangiitis (EGPA), formerly called
2023-510088-37-00
5
2022-03-15
Acyclovir-resistant mucocutaneous HSV infections in immunocompromised
2023-507189-17-00
4
2022-01-09
Muscle-Invasive Urothelial Carcinoma of the Bladder
2022-500385-99-00
5
2021-06-03
SARS-CoV II infection (Coronavirus disease)
2023-505273-33-00
5
2021-02-15
"Adult Subjects with Newly Diagnosed Nontuberculous Mycobacterial
(NTM
2023-508443-40-00
5
2020-12-18
Lung Cancer, Non-Small Cell
2024-515943-44-00
4
2020-10-14
Non small cell lung cancer
2023-507846-96-00
5
2020-06-19
Type 2 Diabetes Mellitus
2024-511427-34-00
5
2020-02-20
idiopathic pulmonary fibrosis
2023-508364-29-00
5
2019-11-22
Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with C
2022-502886-71-00
5
2019-11-20
Previously Untreated Locally Advanced Non-small Cell Lung Cancer (LA N
2024-515308-38-00
5
2019-09-21
Adults patients with isolated acute urticaria presenting to the emerge
2024-515985-16-00
5
2019-04-25
Herpes Simplex Virus Encephalitis
2024-516783-29-00
6
2018-04-16
Severe allergic and eosinophilic asthma
2022-501360-18-00
5
2017-03-15
Early Stage Non-Small Cell Lung Cancer (NSCLC)
2024-517856-36-00
5
2015-03-09
Completely resected primary stage IB (≥ 4cm), II and IIIA non-small ce
2023-507452-77-00
3
Recurrent Pericarditis
2024-512754-16-01
5
Prostate cancer
Showing 241–258 of 258 trials